Infectious Diseases and Clinical Microbiology

Doç. Dr. Müge Ayhan

Doctor and researcher Ankara Bilkent Şehir Hastanesi Ankara
COVID-19Cross InfectionCommunicable Diseases
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Cross Infection 5 publications
  • Communicable Diseases 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologysaglik.gov.trFrom source
  • Department name at the sourceEnfeksiyon Hastalıklarısaglik.gov.trFrom source
  • InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 8 publications · Model version —From source
  • Publications75 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0002-4821-5559ORCIDFrom source
  • Last synchronised5 November 2026 07:22https://ankarasehir.saglik.gov.tr/TR-328006/enfeksiyon-hastaliklari-klinigi-doktorlarimiz.html#muge-ayhansaglik.gov.tr

Scientific work

Publications on COVID-19

75 publications

  1. Effectiveness and safety of molnupiravir among patients with mild to moderate COVID-19: a prospective, observational, cohort study

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-44971-x PMID 41991956 Open-access full textSource: OpenAlex

  2. Clinical management, antifungal susceptibility, and predictors of 28-day mortality in Candidozyma auris candidemia: A single-center cohort study

    Medical Mycology, 2026

    DOI 10.1093/mmy/myag105 PMID 42788966 Open-access full textSource: OpenAlex

  3. Assessing Turkiye’s healthcare-associated infections burden: a multi-centre point-prevalence study benchmarkingagainst the European Centre for Disease Prevention and Control data

    AYBU AVESIS, 2026

    Source: OpenAlex

  4. Comparison of the Clinical Frailty Scale and the FRAIL Scale for predicting short-term outcomes in older adults hospitalized with infectious diseases: a multicentre prospective study

    BMC Geriatrics, 2026

    DOI 10.1186/s12877-026-08634-w Open-access full textSource: OpenAlex

  5. Are Deep Tissue Cultures a Reliable Alternative to Bone Biopsy for Diagnosing Diabetic Foot Osteomyelitis? A Comparative Diagnostic Study

    Diagnostics, 2025

    DOI 10.3390/diagnostics15070880 PMID 40218231 3 citations (Europe PMC) Open-access full textSource: ORCID

  6. Are Deep Tissue Cultures a Reliable Alternative to Bone Biopsy for Diagnosing Diabetic Foot Osteomyelitis? A Comparative Diagnostic Study

    2025

    DOI 10.20944/preprints202503.0896.v1 Open-access full textSource: ORCID

  7. A New Laboratory Tool for COVID-19 Severity Prediction, CENIL Score

    Diagnostics (Basel, Switzerland), 2024

    DOI 10.3390/diagnostics14222557 PMID 39594223 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  8. Point prevalence of antibiotic usage in major referral hospital in Turkey

    PLoS ONE, 2024

    DOI 10.1371/journal.pone.0296900 PMID 38295065 7 citations (OpenAlex) Open-access full textSource: OpenAlex

  9. Infections after musculoskeletal injuries in earthquake survivors

    Joint Diseases and Related Surgery, 2024

    DOI 10.52312/jdrs.2024.1517 PMID 39189579 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac –inactivated COVID-19 vaccines

    Human Vaccines & Immunotherapeutics, 2024

    DOI 10.1080/21645515.2024.2346388 PMID 38924774 2 citations (OpenAlex) Open-access full textSource: OpenAlex

View all 75 publications